Medpace

Provides clinical development services for pharmaceutical and biotechnology.

Launch date

1992

Employees

1001-5000 people

Market cap

Enterprise valuation

€9.6b (Public information from Sep 2024)

Irving Texas (HQ)

http://medpace.com

https://twitter.com/workatmedpace http://www.facebook.com/pages/medpace/131245603567986 https://www.linkedin.com/company/medpace https://apps.apple.com/app/id1367491421 https://play.google.com/store/apps/details?id=com.MedPace

View job openings

Revenues, earnings & profits over time

USD	2020	2021	2022	2023	2024	2025	2026
Revenues	926m	1.1b	1.5b	1.9b	2.1b	2.4b	2.8b
% growth	8 %	23 %	28 %	29 %	14 %	13 %	15 %
EBITDA	187m	220m	301m	365m	446m	500m	582m
% EBITDA margin	20 %	19 %	21 %	19 %	21 %	21 %	21 %
Profit	145m	182m	245m	283m	372m	420m	487m
% profit margin	16 %	16 %	17 %	15 %	17 %	17 %	18 %
EV / revenue	5.0x	6.4x	4.6x	4.9x	4.8x	4.2x	3.5x
EV / EBITDA	25.1x	33.3x	22.4x	25.5x	23.0x	20.1x	16.7x

Date	Investors	Amount	Round
-	CCMP Capital Advisors	N/A	-
Feb 2014	Cinven	$915m Valuation: $915m	Acquisition
Aug 2016	N/A	N/A	IPO
Feb 2023*	HBKS Wealth Advisors	N/A	Post IPO Equity
Dec 2023*	PineStone Asset Management	$9.3m	Post IPO Equity
Total Funding		-

Tech stackLearn more about the technologies and tools that this company uses.

Coherus Biosciences

exited